Skip to content

Comparison of Isovue 370 vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Comparison of the Use of High Iodine Concentration Contrast Material (Isovue 370) vs. Standard Protocol in Coronary Computed Tomographic Angiography (CTA)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02171247
Enrollment
35
Registered
2014-06-24
Start date
2008-04-30
Completion date
2010-12-31
Last updated
2014-08-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Computed Tomographic Angiography

Keywords

coronary computed tomographic angiography, contrast

Brief summary

Computed Tomography Angiogram (CTA) scans are performed routinely to look at the vessels in the body as an alternative to directly injecting contrast into the vessels and taking pictures. Different types of intravenous (into the vein, IV) contrast are available to fill the vessels and make them easier to see. The purpose of the study is to determine the best type of contrast for this scan.

Interventions

Isovue 370 is a contrast agent with increased iodine concentration.

Visipaque 320 is standard protocol.

Sponsors

Duke University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients who are referred for coronary CTA for suspected or known coronary artery disease

Exclusion criteria

* creatinine greater than 2.0 * allergy to contrast media * patients under the age of 18 * women who are pregnant or breast feeding * patients with cardiac arrhythmia will also be excluded

Design outcomes

Primary

MeasureTime frameDescription
Contrast to Noise Ratioduring scan, approximately 3 hoursContrast-to-noise ratios (CNRs) were calculated as follows: CNR = (vascular attenuation - myocardium attenuation) / SD of mean noise attenuation.
Image Qualityduring scan, approximately 3 hoursDepiction of Branch Vessels - coronary branch depiction was performed as consensus decisions of two blinded radiologists. Criteria used was abscence or presence of vessels.
Motion Artifactduring scan, approximately 3 hoursThe outcome will be measured by individual scores. The scores from multiple readers will be averaged.
Attenuation of the Ascending Aorta and Coronary Arteriesduring scan, approximately 3 hoursThe investigator will measure the length of visualized coronary artery for the left anterior descending, left circumflex and right coronary arteries as a way of quantifying visualization of distal coronary segments.

Participant flow

Recruitment details

35 subjects signed consent. 2 subjects were not assigned to a arm and were withdrawn from study due to impaired renal function. 33 subjects completed the study.

Participants by arm

ArmCount
Visipaque 320
Standard protocol is Visipaque 320. Visipaque 320: Visipaque 320 is standard protocol.
16
Isovue 370
Isovue 370 is a contrast agent with increased iodine concentration. Isovue 370: Isovue 370 is a contrast agent with increased iodine concentration.
17
Total33

Baseline characteristics

CharacteristicVisipaque 320Isovue 370Total
Age, Customized
18 years and older
16 participants17 participants33 participants
Region of Enrollment
United States
16 participants17 participants33 participants
Sex: Female, Male
Female
5 Participants6 Participants11 Participants
Sex: Female, Male
Male
11 Participants11 Participants22 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 17
serious
Total, serious adverse events
0 / 160 / 17

Outcome results

Primary

Attenuation of the Ascending Aorta and Coronary Arteries

The investigator will measure the length of visualized coronary artery for the left anterior descending, left circumflex and right coronary arteries as a way of quantifying visualization of distal coronary segments.

Time frame: during scan, approximately 3 hours

ArmMeasureGroupValue (MEAN)Dispersion
Visipaque 320Attenuation of the Ascending Aorta and Coronary Arteriesascending aorta19.5 CNRStandard Deviation 4.8
Visipaque 320Attenuation of the Ascending Aorta and Coronary Arteriescoronary arteries18.4 CNRStandard Deviation 5.3
Isovue 370Attenuation of the Ascending Aorta and Coronary Arteriesascending aorta21.6 CNRStandard Deviation 4.2
Isovue 370Attenuation of the Ascending Aorta and Coronary Arteriescoronary arteries20.3 CNRStandard Deviation 4.6
Primary

Contrast to Noise Ratio

Contrast-to-noise ratios (CNRs) were calculated as follows: CNR = (vascular attenuation - myocardium attenuation) / SD of mean noise attenuation.

Time frame: during scan, approximately 3 hours

ArmMeasureValue (MEAN)Dispersion
Visipaque 320Contrast to Noise Ratio18.6 CNRStandard Deviation 5.2
Isovue 370Contrast to Noise Ratio20.5 CNRStandard Deviation 4.5
Primary

Image Quality

Depiction of Branch Vessels - coronary branch depiction was performed as consensus decisions of two blinded radiologists. Criteria used was abscence or presence of vessels.

Time frame: during scan, approximately 3 hours

ArmMeasureGroupValue (NUMBER)
Visipaque 320Image QualityConus43.8 % of coronary branches visualized
Visipaque 320Image QualitySinoatrial Nodal37.5 % of coronary branches visualized
Visipaque 320Image QualityDiagonal187.5 % of coronary branches visualized
Visipaque 320Image QualityDiagonal1 and Diagonal212.5 % of coronary branches visualized
Visipaque 320Image QualityObutse Marginal168.8 % of coronary branches visualized
Visipaque 320Image QualityObutse Marginal1 and Obutse Marginal26.3 % of coronary branches visualized
Visipaque 320Image QualityAcute marginal162.5 % of coronary branches visualized
Visipaque 320Image QualityAcute marginal1 and Acute marginal218.8 % of coronary branches visualized
Visipaque 320Image QualitySeptal perforator43.8 % of coronary branches visualized
Visipaque 320Image QualityPosterolateral6.3 % of coronary branches visualized
Isovue 370Image QualityAcute marginal1 and Acute marginal252.9 % of coronary branches visualized
Isovue 370Image QualityConus94.1 % of coronary branches visualized
Isovue 370Image QualityObutse Marginal1 and Obutse Marginal270.6 % of coronary branches visualized
Isovue 370Image QualitySinoatrial Nodal82.4 % of coronary branches visualized
Isovue 370Image QualityPosterolateral64.7 % of coronary branches visualized
Isovue 370Image QualityDiagonal135.3 % of coronary branches visualized
Isovue 370Image QualityAcute marginal147.1 % of coronary branches visualized
Isovue 370Image QualityDiagonal1 and Diagonal264.7 % of coronary branches visualized
Isovue 370Image QualitySeptal perforator88.2 % of coronary branches visualized
Isovue 370Image QualityObutse Marginal129.4 % of coronary branches visualized
Primary

Motion Artifact

The outcome will be measured by individual scores. The scores from multiple readers will be averaged.

Time frame: during scan, approximately 3 hours

Population: Data was not collected and therefore not analysed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026